These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27178121)

  • 21. A ΔRaf1-ER-inducible oncogenic zebrafish liver cell model identifies hepatocellular carcinoma signatures.
    He S; Krens SG; Zhan H; Gong Z; Hogendoorn PC; Spaink HP; Snaar-Jagalska BE
    J Pathol; 2011 Sep; 225(1):19-28. PubMed ID: 21744342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An ShRNA Based Genetic Screen Identified Sesn2 as a Potential Tumor Suppressor in Lung Cancer via Suppression of Akt-mTOR-p70S6K Signaling.
    Xu H; Sun H; Zhang H; Liu J; Fan F; Li Y; Ning X; Sun Y; Dai S; Liu B; Gao M; Fu S; Zhou C
    PLoS One; 2015; 10(5):e0124033. PubMed ID: 25962159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes.
    Teng YC; Shen ZQ; Kao CH; Tsai TF
    World J Gastroenterol; 2016 Jan; 22(1):300-25. PubMed ID: 26755878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic deletion of RALA and RALB small GTPases reveals redundant functions in development and tumorigenesis.
    Peschard P; McCarthy A; Leblanc-Dominguez V; Yeo M; Guichard S; Stamp G; Marshall CJ
    Curr Biol; 2012 Nov; 22(21):2063-8. PubMed ID: 23063435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
    Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
    World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncogenic mutations and dysregulated pathways in obesity-associated hepatocellular carcinoma.
    Shen J; Tsoi H; Liang Q; Chu ES; Liu D; Yu AC; Chan TF; Li X; Sung JJ; Wong VW; Yu J
    Oncogene; 2016 Dec; 35(49):6271-6280. PubMed ID: 27132506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice.
    Pasquinelli C; Bhavani K; Chisari FV
    Cancer Res; 1992 May; 52(10):2823-9. PubMed ID: 1316229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA TUC338 is functionally involved in sorafenib-sensitized hepatocarcinoma cells by targeting RASAL1.
    Jin W; Chen L; Cai X; Zhang Y; Zhang J; Ma D; Cai X; Fu T; Yu Z; Yu F; Chen G
    Oncol Rep; 2017 Jan; 37(1):273-280. PubMed ID: 27878301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pivotal role of mTOR signaling in hepatocellular carcinoma.
    Villanueva A; Chiang DY; Newell P; Peix J; Thung S; Alsinet C; Tovar V; Roayaie S; Minguez B; Sole M; Battiston C; Van Laarhoven S; Fiel MI; Di Feo A; Hoshida Y; Yea S; Toffanin S; Ramos A; Martignetti JA; Mazzaferro V; Bruix J; Waxman S; Schwartz M; Meyerson M; Friedman SL; Llovet JM
    Gastroenterology; 2008 Dec; 135(6):1972-83, 1983.e1-11. PubMed ID: 18929564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HBx-related long non-coding RNA DBH-AS1 promotes cell proliferation and survival by activating MAPK signaling in hepatocellular carcinoma.
    Huang JL; Ren TY; Cao SW; Zheng SH; Hu XM; Hu YW; Lin L; Chen J; Zheng L; Wang Q
    Oncotarget; 2015 Oct; 6(32):33791-804. PubMed ID: 26393879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Small nucleolar RNA ACA11 promotes proliferation, migration and invasion in hepatocellular carcinoma by targeting the PI3K/AKT signaling pathway.
    Wu L; Zheng J; Chen P; Liu Q; Yuan Y
    Biomed Pharmacother; 2017 Jun; 90():705-712. PubMed ID: 28419966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RalA, a GTPase targeted by miR-181a, promotes transformation and progression by activating the Ras-related signaling pathway in chronic myelogenous leukemia.
    Gu C; Feng M; Yin Z; Luo X; Yang J; Li Y; Li T; Wang R; Fei J
    Oncotarget; 2016 Apr; 7(15):20561-73. PubMed ID: 26967392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
    Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
    Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
    Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
    J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
    Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
    J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of Rab17 promotes tumourigenic properties of hepatocellular carcinoma cells via Erk pathway.
    Qi J; Zhao P; Li F; Guo Y; Cui H; Liu A; Mao H; Zhao Y; Zhang X
    Int J Clin Exp Pathol; 2015; 8(5):4963-71. PubMed ID: 26191189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNA interference against cancer/testis genes identifies dual specificity phosphatase 21 as a potential therapeutic target in human hepatocellular carcinoma.
    Deng Q; Li KY; Chen H; Dai JH; Zhai YY; Wang Q; Li N; Wang YP; Han ZG
    Hepatology; 2014 Feb; 59(2):518-30. PubMed ID: 23929653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma.
    Wong CM; Ng YL; Lee JM; Wong CC; Cheung OF; Chan CY; Tung EK; Ching YP; Ng IO
    Hepatology; 2007 May; 45(5):1129-38. PubMed ID: 17464989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery and characterization of small molecules that target the GTPase Ral.
    Yan C; Liu D; Li L; Wempe MF; Guin S; Khanna M; Meier J; Hoffman B; Owens C; Wysoczynski CL; Nitz MD; Knabe WE; Ahmed M; Brautigan DL; Paschal BM; Schwartz MA; Jones DN; Ross D; Meroueh SO; Theodorescu D
    Nature; 2014 Nov; 515(7527):443-7. PubMed ID: 25219851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of RalA is critical for Ras-induced tumorigenesis of human cells.
    Lim KH; Baines AT; Fiordalisi JJ; Shipitsin M; Feig LA; Cox AD; Der CJ; Counter CM
    Cancer Cell; 2005 Jun; 7(6):533-45. PubMed ID: 15950903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.